Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response.

Ling, Chen; Zhou, Xiuman; Gao, Yanfeng; Sui, Xinghua

Ling, Chen; Zhou, Xiuman; Gao, Yanfeng; Sui, Xinghua.

Afiliação

Ling C; School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Zhou X; School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Gao Y; School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Sui X; School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.

Pharmaceuticals (Basel) ; 15(5)2022 May 14.

Article em En | MEDLINE | ID: mdl-35631431

Palavras-chave

esophageal adenocarcinoma; immune checkpoint inhibitors; immunotherapy response; molecular subtypes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google